In summary, we performed comprehensive bioinformatics analysis and identified three pyroptosis-related diagnostic biomarker genes (TREM1, TNFRSF11B, and PGF) that were significantly associated with CAVD progression. This evidence concerns the gene PGF and congenital bilateral aplasia of vas deferens from CFTR mutation.